Semaglutide is normally effectively tolerated with comparable dropout costs when compared with placebo, although it could possibly be much less properly tolerated than dulaglutide (Trulicity).1,three The commonest adverse consequences are nausea, vomiting, and diarrhea and may be knowledgeable by about thirty% of individuals, normally when the dose